procainamide has been researched along with Acquired Autoimmune Hemolytic Anemia in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kleinman, S | 1 |
Nelson, R | 1 |
Smith, L | 1 |
Goldfinger, D | 1 |
Wautier, JL | 1 |
Rouger, P | 1 |
1 review available for procainamide and Acquired Autoimmune Hemolytic Anemia
Article | Year |
---|---|
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetab | 2001 |
1 other study available for procainamide and Acquired Autoimmune Hemolytic Anemia
Article | Year |
---|---|
Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Coombs Test; Erythrocytes; Humans; Mal | 1984 |